The results of this project will assess menorrhagia score and quality of life improvement after the UAE procedure, and define the association of VEGF and TGF-β blood levels with fibroid shrinkage in patients undergoing UAE, thus, improving knowledge of biochemical markers’ role and approach to clinical management of women with uterine fibroids. The gene discussed is TGFB1; the disease is Menorrhagia.